reiterateBLZEfinnhub
B. Riley Securities Reiterates Buy Rating on Backblaze, Inc. (BLZE)
Rating Change B. Riley Securities analysts reiterated a Buy rating on Backblaze, Inc. (NASDAQ:BLZE) on August 04, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change B. Riley Securities analysts reiterated a Buy rating on Backblaze, Inc. (NASDAQ:BLZE) on August 04, 2026.
Read moreRating Change Benchmark analysts initiated coverage on Inflection Point Acquisition Corp. V (NASDAQ:IPEXR) with a Buy rating on August 04, 2026. Market Context Inflection Point…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Bank of Marin Bancorp (NASDAQ:BMRC) on August 04, 2026. Market Context Bank of Marin Bancorp…
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on August 04, 2026. Market Context Adaptive…
Read moreRating Change Freedom Capital Markets analysts downgraded Integer Holdings Corporation (NYSE:ITGR) from Buy to Hold on August 04, 2026. Market Context Integer Holdings Corporation…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Integer Holdings Corporation (NYSE:ITGR) on August 04, 2026. Market Context Integer Holdings Corporation…
Read moreRating Change Wells Fargo analysts downgraded Olin Corporation (NYSE:OLN) from Overweight to Equal-Weight on August 04, 2026. Market Context Olin Corporation operates in the Basic…
Read moreRating Change Goldman Sachs analysts reiterated a Neutral rating on Olin Corporation (NYSE:OLN) on August 04, 2026. Market Context Olin Corporation operates in the Basic Materials…
Read moreRating Change Chardan Capital analysts reiterated a Buy rating on Ocular Therapeutix, Inc. (NASDAQ:OCUL) on August 04, 2026. Market Context Ocular Therapeutix, Inc.
Read moreRating Change Baird analysts reiterated a Outperform rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on August 04, 2026. Market Context Jazz Pharmaceuticals plc operates in the…
Read moreRating Change Needham analysts reiterated a Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on August 04, 2026. Market Context Jazz Pharmaceuticals plc operates in the…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on August 04, 2026. Market Context Jazz Pharmaceuticals plc operates in…
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on August 04, 2026. Market Context Jazz Pharmaceuticals plc operates…
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on August 04, 2026. Market Context Jazz Pharmaceuticals plc operates…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on August 04, 2026. Market Context Jazz Pharmaceuticals plc operates in…
Read moreFiling Details CITIGROUP INC, a registered investment adviser, initiated a new position in Broadcom Inc. (NASDAQ:AVGO) during Q2 2026, according to its most recent 13F filing with…
Read moreFiling Details Walleye Trading LLC, a registered investment adviser, increased its position in Meta Platforms, Inc. (NASDAQ:META) by 50.0% during Q2 2026, according to its most…
Read moreFiling Details Walleye Trading LLC, a registered investment adviser, reduced its position in Arm Holdings plc American Depositary Shares (NASDAQ:ARM) during Q2 2026, according to…
Read moreFiling Details MASSACHUSETTS FINANCIAL SERVICES CO /MA/, a registered investment adviser, initiated a new position in Boston Scientific Corporation (NYSE:BSX) during Q2 2026,…
Read moreFiling Details MASSACHUSETTS FINANCIAL SERVICES CO /MA/, a registered investment adviser, initiated a new position in Vulcan Materials Company (NYSE:VMC) during Q2 2026, according…
Read more